Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Dara Aisner

Concepts (414)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
66
2025
2342
5.080
 Why?
Carcinoma, Non-Small-Cell Lung
45
2025
1049
3.850
 Why?
Genetic Testing
9
2022
430
2.290
 Why?
ErbB Receptors
22
2025
607
2.270
 Why?
Mutation
41
2025
3717
2.160
 Why?
Pathology, Molecular
7
2019
25
2.050
 Why?
Oncogene Proteins, Fusion
13
2019
201
1.940
 Why?
Protein Kinase Inhibitors
26
2025
887
1.800
 Why?
High-Throughput Nucleotide Sequencing
14
2023
487
1.790
 Why?
Molecular Diagnostic Techniques
3
2020
98
1.590
 Why?
Proto-Oncogene Proteins B-raf
13
2022
210
1.410
 Why?
Neoplasms
12
2023
2455
1.380
 Why?
Proto-Oncogene Proteins
17
2018
636
1.380
 Why?
Protein-Tyrosine Kinases
12
2018
431
1.330
 Why?
Biomarkers, Tumor
18
2024
1164
1.180
 Why?
Receptor Protein-Tyrosine Kinases
10
2019
231
1.080
 Why?
DNA, Neoplasm
3
2019
157
1.080
 Why?
Antineoplastic Agents
16
2024
2046
1.070
 Why?
Proto-Oncogene Proteins p21(ras)
11
2020
259
1.030
 Why?
Drug Resistance, Neoplasm
13
2023
752
0.950
 Why?
Proto-Oncogene Proteins c-met
5
2019
74
0.930
 Why?
Colorectal Neoplasms
3
2022
749
0.830
 Why?
Acrylamides
5
2025
57
0.820
 Why?
Gene Rearrangement
13
2019
148
0.810
 Why?
Adenocarcinoma
9
2018
893
0.800
 Why?
Molecular Targeted Therapy
11
2024
391
0.750
 Why?
Brain Neoplasms
10
2018
1145
0.750
 Why?
Ganglioglioma
4
2014
27
0.750
 Why?
DNA Mutational Analysis
11
2020
382
0.710
 Why?
Aniline Compounds
4
2025
97
0.690
 Why?
Precision Medicine
4
2018
387
0.670
 Why?
Humans
122
2025
129625
0.670
 Why?
Pyrazoles
10
2018
404
0.650
 Why?
Adenocarcinoma, Mucinous
2
2022
73
0.650
 Why?
Insurance, Health, Reimbursement
1
2020
94
0.640
 Why?
Neoplasms, Muscle Tissue
1
2019
5
0.640
 Why?
Immunohistochemistry
10
2023
1685
0.630
 Why?
Prognosis
14
2024
3774
0.630
 Why?
Receptors, Nerve Growth Factor
1
2019
17
0.630
 Why?
Antineoplastic Combined Chemotherapy Protocols
7
2024
1560
0.630
 Why?
Biological Products
1
2022
205
0.620
 Why?
Astrocytoma
3
2015
115
0.620
 Why?
Neoplasm Metastasis
10
2024
611
0.610
 Why?
Insurance Coverage
1
2020
219
0.600
 Why?
In Situ Hybridization, Fluorescence
13
2019
313
0.570
 Why?
Laboratory Proficiency Testing
2
2023
9
0.570
 Why?
Computational Biology
4
2023
596
0.550
 Why?
RNA
5
2019
882
0.500
 Why?
Tumor Suppressor Protein p53
3
2023
507
0.490
 Why?
Small Cell Lung Carcinoma
1
2016
88
0.460
 Why?
Neoplasm Staging
13
2024
1282
0.460
 Why?
Aged, 80 and over
18
2025
7052
0.450
 Why?
Smoking
3
2018
1500
0.450
 Why?
Pyrimidines
6
2025
459
0.440
 Why?
ras Proteins
5
2015
144
0.440
 Why?
Pyridines
8
2016
478
0.430
 Why?
Mesothelioma
2
2024
38
0.420
 Why?
Neoplasm Recurrence, Local
3
2022
958
0.420
 Why?
Aged
32
2025
22061
0.400
 Why?
AMP-Activated Protein Kinases
1
2014
191
0.390
 Why?
Male
52
2025
63670
0.380
 Why?
Female
53
2025
68734
0.380
 Why?
Middle Aged
40
2025
31136
0.370
 Why?
Telomerase
7
2002
234
0.360
 Why?
TOR Serine-Threonine Kinases
1
2014
398
0.360
 Why?
S100 Proteins
2
2014
36
0.360
 Why?
Neoadjuvant Therapy
3
2024
379
0.360
 Why?
Pleural Neoplasms
2
2024
24
0.350
 Why?
Genomics
4
2023
718
0.340
 Why?
Sulfones
3
2015
108
0.320
 Why?
Early Detection of Cancer
2
2019
370
0.320
 Why?
Curriculum
1
2016
920
0.320
 Why?
Glycine
3
2015
165
0.310
 Why?
Laboratories
2
2023
108
0.310
 Why?
Adult
35
2025
35599
0.300
 Why?
Adrenal Gland Neoplasms
2
2022
83
0.290
 Why?
Head and Neck Neoplasms
3
2019
544
0.280
 Why?
Neoplasms, Multiple Primary
2
2022
55
0.270
 Why?
Treatment Outcome
12
2024
10219
0.270
 Why?
Class I Phosphatidylinositol 3-Kinases
4
2022
81
0.270
 Why?
Indoles
5
2025
383
0.270
 Why?
Oncogene Fusion
2
2019
14
0.270
 Why?
Gene Dosage
2
2018
143
0.270
 Why?
Receptor, Fibroblast Growth Factor, Type 1
2
2018
51
0.260
 Why?
Exons
5
2019
342
0.260
 Why?
Survival Analysis
5
2025
1269
0.260
 Why?
Antineoplastic Agents, Immunological
2
2018
181
0.260
 Why?
Melanoma
2
2020
730
0.260
 Why?
Genetic Predisposition to Disease
6
2019
2274
0.250
 Why?
Phosphatidylinositol 3-Kinases
4
2023
361
0.250
 Why?
Oncogenes
3
2016
110
0.240
 Why?
Sodium-Phosphate Cotransporter Proteins, Type IIb
3
2015
9
0.240
 Why?
Receptor, ErbB-2
4
2022
326
0.240
 Why?
Immunotherapy
5
2022
596
0.230
 Why?
Pemetrexed
1
2024
32
0.230
 Why?
Epithelioid Cells
2
2015
8
0.230
 Why?
Sensitivity and Specificity
5
2019
1843
0.210
 Why?
Fetomaternal Transfusion
1
2023
11
0.210
 Why?
Carcinoma, Squamous Cell
3
2019
627
0.210
 Why?
Cell Line, Tumor
11
2018
3186
0.200
 Why?
Choriocarcinoma
1
2022
9
0.200
 Why?
Endodermal Sinus Tumor
1
2022
9
0.200
 Why?
Tertiary Care Centers
1
2023
148
0.200
 Why?
Pathologists
2
2023
16
0.200
 Why?
Young Adult
13
2024
12455
0.190
 Why?
Goals
1
2023
159
0.190
 Why?
Patient Selection
4
2018
661
0.190
 Why?
Biopsy, Fine-Needle
2
2012
67
0.190
 Why?
Gene Fusion
2
2018
25
0.190
 Why?
Hematologic Neoplasms
1
2023
141
0.190
 Why?
Endometrial Neoplasms
1
2023
162
0.180
 Why?
Cell Proliferation
7
2017
2373
0.180
 Why?
Neoplasms, Germ Cell and Embryonal
1
2022
70
0.180
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2022
33
0.180
 Why?
Graft vs Host Disease
1
2023
240
0.180
 Why?
Biopsy
4
2018
1088
0.180
 Why?
Pheochromocytoma
1
2022
57
0.180
 Why?
Combined Modality Therapy
4
2018
1203
0.180
 Why?
Trastuzumab
1
2021
100
0.180
 Why?
Carbazoles
1
2021
84
0.180
 Why?
Meningioma
1
2022
81
0.180
 Why?
Glioblastoma
2
2015
322
0.170
 Why?
Laboratories, Hospital
1
2020
14
0.170
 Why?
United States
9
2020
13871
0.170
 Why?
Government Regulation
1
2020
49
0.170
 Why?
Pathology, Clinical
2
2017
36
0.170
 Why?
GTP Phosphohydrolases
1
2020
86
0.170
 Why?
Piperidines
1
2021
201
0.160
 Why?
Costs and Cost Analysis
1
2020
201
0.160
 Why?
Stakeholder Participation
1
2020
75
0.160
 Why?
Cell Transformation, Neoplastic
3
2018
326
0.160
 Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
2
2017
55
0.160
 Why?
Chromosome Aberrations
2
2019
147
0.160
 Why?
Genes, erbB-2
2
2015
28
0.160
 Why?
Multiplex Polymerase Chain Reaction
1
2019
51
0.150
 Why?
Smad4 Protein
1
2019
38
0.150
 Why?
Genetic Heterogeneity
1
2019
58
0.150
 Why?
Pregnancy Complications
1
2023
493
0.150
 Why?
Breast Neoplasms, Male
1
2018
29
0.150
 Why?
Multigene Family
1
2019
199
0.150
 Why?
Genetic Markers
1
2019
336
0.150
 Why?
Pyridazines
1
2018
54
0.150
 Why?
Cell Cycle Proteins
4
2015
584
0.150
 Why?
Database Management Systems
1
2018
48
0.150
 Why?
Piperazines
2
2018
340
0.140
 Why?
Gene Frequency
1
2019
502
0.140
 Why?
Genetic Association Studies
1
2019
362
0.140
 Why?
Quinazolines
3
2014
243
0.140
 Why?
Thromboembolism
1
2018
112
0.140
 Why?
Programmed Cell Death 1 Receptor
2
2018
232
0.140
 Why?
Cell-Free Nucleic Acids
1
2018
32
0.140
 Why?
Smokers
1
2018
138
0.140
 Why?
Skin Neoplasms
2
2020
829
0.140
 Why?
Imidazoles
1
2018
234
0.140
 Why?
Radiotherapy, Intensity-Modulated
1
2018
129
0.140
 Why?
Intraoperative Care
1
2017
46
0.140
 Why?
Leukemia, Myeloid, Acute
1
2024
596
0.140
 Why?
Retrospective Studies
11
2025
14522
0.140
 Why?
Gene Deletion
1
2019
382
0.140
 Why?
Medical Informatics
1
2018
99
0.140
 Why?
Ovarian Neoplasms
1
2022
484
0.140
 Why?
Chloroquine
1
2017
51
0.130
 Why?
B7-H1 Antigen
1
2018
198
0.130
 Why?
Small Molecule Libraries
1
2017
86
0.130
 Why?
Clinical Decision-Making
1
2019
301
0.130
 Why?
Pleural Effusion, Malignant
1
2016
10
0.130
 Why?
Coculture Techniques
1
2017
223
0.130
 Why?
Disease Progression
6
2024
2627
0.130
 Why?
RNA, Messenger
4
2018
2708
0.130
 Why?
Carcinogenesis
1
2017
213
0.130
 Why?
Sulfonamides
2
2017
497
0.120
 Why?
Proto-Oncogene Proteins c-kit
1
2016
63
0.120
 Why?
Immunity, Humoral
1
2016
118
0.120
 Why?
Codon
1
2016
86
0.120
 Why?
Neoplastic Cells, Circulating
1
2016
70
0.120
 Why?
Triple Negative Breast Neoplasms
1
2018
193
0.120
 Why?
Positron Emission Tomography Computed Tomography
1
2016
87
0.120
 Why?
Peritoneal Neoplasms
1
2016
86
0.120
 Why?
Protein Kinases
1
2017
318
0.120
 Why?
Oncogene Proteins
1
2015
55
0.120
 Why?
Signal Transduction
5
2017
4931
0.120
 Why?
Fatal Outcome
1
2016
300
0.120
 Why?
Clinical Laboratory Techniques
1
2016
94
0.120
 Why?
Practice Guidelines as Topic
2
2019
1501
0.120
 Why?
Liver Neoplasms
3
2015
639
0.120
 Why?
Sequence Analysis, RNA
1
2017
427
0.120
 Why?
Amino Acid Substitution
1
2016
283
0.120
 Why?
Medical Oncology
3
2023
269
0.120
 Why?
Medicare
1
2020
708
0.120
 Why?
Hamartoma
1
2015
21
0.120
 Why?
Immunity, Cellular
1
2016
265
0.120
 Why?
Genetic Variation
1
2019
939
0.110
 Why?
Pharmacogenetics
1
2016
172
0.110
 Why?
Meningeal Carcinomatosis
1
2014
8
0.110
 Why?
Spinal Cord Neoplasms
1
2014
36
0.110
 Why?
Autophagy
1
2017
266
0.110
 Why?
DNA Copy Number Variations
4
2018
168
0.110
 Why?
Deoxycytidine
1
2015
164
0.110
 Why?
Health Care Surveys
1
2016
557
0.110
 Why?
Speech Disorders
1
2014
34
0.110
 Why?
Paresis
1
2014
30
0.110
 Why?
Multimodal Imaging
1
2015
110
0.110
 Why?
Membrane Proteins
1
2020
1125
0.110
 Why?
Alternative Splicing
3
2017
217
0.110
 Why?
Lung Transplantation
1
2016
289
0.110
 Why?
Polymerase Chain Reaction
2
2014
1035
0.110
 Why?
Mitogen-Activated Protein Kinases
1
2015
312
0.110
 Why?
Receptor, trkA
1
2013
16
0.110
 Why?
Wnt Signaling Pathway
1
2015
170
0.110
 Why?
Tumor Cells, Cultured
5
2019
943
0.110
 Why?
Intracranial Hemorrhages
1
2014
78
0.110
 Why?
Microscopy, Electron
1
2014
426
0.110
 Why?
Dose-Response Relationship, Drug
5
2021
2011
0.100
 Why?
Positron-Emission Tomography
1
2015
282
0.100
 Why?
Sarcoma
1
2015
176
0.100
 Why?
Societies, Medical
4
2018
744
0.100
 Why?
Serine Endopeptidases
1
2013
120
0.100
 Why?
Brain Stem Neoplasms
1
2013
81
0.100
 Why?
Headache
1
2014
151
0.100
 Why?
Graft Rejection
1
2016
598
0.100
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2017
949
0.100
 Why?
Gene Expression Regulation, Neoplastic
1
2019
1336
0.100
 Why?
Bone Neoplasms
1
2015
229
0.100
 Why?
Tissue Fixation
1
2012
33
0.100
 Why?
Microtubule-Associated Proteins
1
2013
192
0.100
 Why?
Recombinant Fusion Proteins
2
2013
651
0.100
 Why?
Predictive Value of Tests
2
2015
1947
0.100
 Why?
Gene Amplification
3
2019
104
0.100
 Why?
Mutation Rate
1
2011
25
0.090
 Why?
Lung
4
2015
3938
0.090
 Why?
Education, Medical, Graduate
1
2016
442
0.090
 Why?
Algorithms
1
2019
1616
0.090
 Why?
Translocation, Genetic
1
2012
96
0.090
 Why?
Tomography, X-Ray Computed
3
2018
2512
0.090
 Why?
Interdisciplinary Communication
1
2012
184
0.090
 Why?
Specimen Handling
1
2012
162
0.090
 Why?
Teratoma
1
2011
103
0.090
 Why?
Epithelial Cells
1
2017
1075
0.090
 Why?
Terminology as Topic
1
2012
203
0.090
 Why?
Rhabdoid Tumor
1
2011
95
0.090
 Why?
Prospective Studies
2
2023
7135
0.080
 Why?
DNA-Binding Proteins
6
2011
1445
0.080
 Why?
Genome, Human
1
2012
394
0.080
 Why?
Breast Neoplasms
1
2022
2133
0.080
 Why?
Xenograft Model Antitumor Assays
3
2019
808
0.080
 Why?
Phosphorylation
1
2014
1713
0.080
 Why?
Immunoenzyme Techniques
3
2015
212
0.080
 Why?
Erlotinib Hydrochloride
3
2014
70
0.080
 Why?
Survival Rate
4
2019
1872
0.080
 Why?
Disease-Free Survival
3
2016
646
0.080
 Why?
Catheter Ablation
1
2012
336
0.080
 Why?
Telomere
3
2000
233
0.080
 Why?
Leukemia-Lymphoma, Adult T-Cell
1
2008
13
0.070
 Why?
Hematopoietic Stem Cell Transplantation
2
2024
576
0.070
 Why?
Proto-Oncogene Proteins c-ret
2
2018
30
0.070
 Why?
beta Catenin
2
2023
225
0.070
 Why?
Diagnosis, Differential
1
2012
1432
0.070
 Why?
Follow-Up Studies
4
2021
4894
0.070
 Why?
Maximum Tolerated Dose
2
2021
193
0.070
 Why?
Heart Neoplasms
1
2008
50
0.070
 Why?
Pancreatic Neoplasms
1
2015
880
0.070
 Why?
Adolescent
6
2019
20412
0.070
 Why?
DNA
1
2014
1404
0.070
 Why?
Reproducibility of Results
3
2019
3080
0.070
 Why?
Workflow
2
2017
156
0.060
 Why?
Internship and Residency
1
2016
1050
0.060
 Why?
Eye Neoplasms
1
2005
16
0.060
 Why?
Mental Disorders
1
2014
1034
0.060
 Why?
Pleura
1
2024
22
0.060
 Why?
Immunophenotyping
1
2005
311
0.060
 Why?
Administration, Oral
2
2018
787
0.050
 Why?
Induction Chemotherapy
1
2024
70
0.050
 Why?
Poly-ADP-Ribose Binding Proteins
1
2023
33
0.050
 Why?
DNA Polymerase II
1
2023
38
0.050
 Why?
Peritoneum
1
2023
41
0.050
 Why?
Real-Time Polymerase Chain Reaction
2
2015
329
0.050
 Why?
Genes, ras
2
2015
95
0.050
 Why?
DNA Mismatch Repair
1
2023
47
0.050
 Why?
Antigens, Differentiation, B-Lymphocyte
2
2013
37
0.050
 Why?
Leukocyte Count
1
2024
326
0.050
 Why?
Blotting, Western
4
2015
1206
0.050
 Why?
Carcinoma, Endometrioid
1
2022
44
0.050
 Why?
Cell Cycle
2
2012
588
0.050
 Why?
Cell Survival
2
2017
1076
0.050
 Why?
Magnetic Resonance Imaging
1
2014
3394
0.050
 Why?
Active Transport, Cell Nucleus
1
2002
113
0.050
 Why?
Clinical Trials as Topic
2
2017
1005
0.050
 Why?
Histocompatibility Antigens Class II
2
2013
363
0.050
 Why?
Gene Expression Regulation, Enzymologic
1
2002
285
0.040
 Why?
Gene Expression Profiling
2
2017
1687
0.040
 Why?
Models, Molecular
2
2018
1491
0.040
 Why?
Standard of Care
1
2020
71
0.040
 Why?
Base Sequence
3
2017
2147
0.040
 Why?
Protein Processing, Post-Translational
1
2002
457
0.040
 Why?
Time Factors
3
2020
6555
0.040
 Why?
HSP90 Heat-Shock Proteins
1
1999
45
0.040
 Why?
Fetus
1
2023
774
0.040
 Why?
Tumor Microenvironment
1
2023
627
0.040
 Why?
Cell Nucleus
1
2002
584
0.040
 Why?
Catalytic Domain
4
2000
220
0.040
 Why?
Sequence Deletion
2
2014
179
0.040
 Why?
Cohort Studies
2
2019
5426
0.040
 Why?
Radiotherapy, Image-Guided
1
2018
34
0.040
 Why?
Aurora Kinase A
1
2018
54
0.040
 Why?
Cell Line
4
2012
2784
0.040
 Why?
RNA, Untranslated
1
1999
118
0.040
 Why?
Proto-Oncogenes
1
2018
29
0.040
 Why?
Phthalazines
1
2018
41
0.040
 Why?
Nausea
1
2018
111
0.040
 Why?
Cetuximab
1
2018
94
0.040
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2017
24
0.040
 Why?
Breast
1
2018
153
0.030
 Why?
Diarrhea
1
2018
182
0.030
 Why?
Child
5
2015
20884
0.030
 Why?
Quality Control
1
2017
163
0.030
 Why?
A549 Cells
1
2017
59
0.030
 Why?
Molecular Sequence Data
3
2013
2835
0.030
 Why?
Structure-Activity Relationship
1
2018
545
0.030
 Why?
Pathology, Surgical
1
2016
8
0.030
 Why?
Fatigue
1
2018
318
0.030
 Why?
Centrosome
1
2016
64
0.030
 Why?
Drug Synergism
1
2017
370
0.030
 Why?
Carcinoma
2
2012
214
0.030
 Why?
Dual Specificity Phosphatase 6
1
2015
6
0.030
 Why?
Transcription, Genetic
1
2002
1418
0.030
 Why?
Genes, erbB-1
1
2015
17
0.030
 Why?
Child, Preschool
3
2015
10490
0.030
 Why?
Mice, Nude
1
2017
682
0.030
 Why?
Lamin Type A
1
2015
48
0.030
 Why?
Cell Line, Transformed
3
2000
141
0.030
 Why?
Mitogen-Activated Protein Kinase Kinases
1
2015
131
0.030
 Why?
MAP Kinase Kinase 1
1
2015
75
0.030
 Why?
Multivariate Analysis
1
2018
1499
0.030
 Why?
Antimetabolites, Antineoplastic
1
2015
91
0.030
 Why?
Consensus
1
2018
618
0.030
 Why?
HEK293 Cells
1
2017
698
0.030
 Why?
Sequence Analysis, DNA
1
2017
778
0.030
 Why?
Respiratory Mucosa
1
2017
310
0.030
 Why?
Radiopharmaceuticals
1
2015
168
0.030
 Why?
Fluorodeoxyglucose F18
1
2015
128
0.030
 Why?
Recurrence
1
2017
1011
0.030
 Why?
Intercellular Signaling Peptides and Proteins
1
2015
374
0.030
 Why?
Antibodies, Monoclonal, Humanized
1
2018
757
0.030
 Why?
Microdissection
1
2013
15
0.030
 Why?
Animals
5
2019
35391
0.030
 Why?
Epidermal Growth Factor
1
2013
169
0.030
 Why?
Drug Administration Schedule
1
2015
767
0.030
 Why?
Disease Management
1
2017
588
0.030
 Why?
Syndecan-4
1
2012
7
0.030
 Why?
Proto-Oncogene Proteins c-akt
1
2015
432
0.030
 Why?
Papillomaviridae
1
2013
114
0.030
 Why?
Randomized Controlled Trials as Topic
1
2018
1365
0.020
 Why?
Cooperative Behavior
1
2015
433
0.020
 Why?
Transcriptome
1
2018
876
0.020
 Why?
Bone and Bones
1
2015
294
0.020
 Why?
SMARCB1 Protein
1
2011
29
0.020
 Why?
Incidence
1
2018
2641
0.020
 Why?
Hyperglycemia
1
2015
327
0.020
 Why?
Green Fluorescent Proteins
1
2012
388
0.020
 Why?
Chromosomal Proteins, Non-Histone
1
2011
116
0.020
 Why?
Mice
2
2019
16961
0.020
 Why?
Lymphatic Metastasis
1
2012
320
0.020
 Why?
Pregnancy
1
2023
6417
0.020
 Why?
Bronchoscopy
1
2012
216
0.020
 Why?
Adaptor Proteins, Signal Transducing
1
2013
399
0.020
 Why?
Infant
2
2015
8995
0.020
 Why?
Enzyme Inhibitors
1
2014
827
0.020
 Why?
Cognition Disorders
1
2014
505
0.020
 Why?
Polymorphism, Single Nucleotide
1
2017
2060
0.020
 Why?
Papillomavirus Infections
1
2013
297
0.020
 Why?
Retroviridae
2
2000
99
0.020
 Why?
Reticulocytes
2
1999
18
0.020
 Why?
Protein Structure, Tertiary
1
2012
843
0.020
 Why?
Hypertension
1
2018
1243
0.020
 Why?
Cells, Cultured
1
2017
4084
0.020
 Why?
Sex Factors
1
2015
1970
0.020
 Why?
Genetic Vectors
2
2000
314
0.020
 Why?
Leukemic Infiltration
1
2008
5
0.020
 Why?
DNA Primers
2
1999
511
0.020
 Why?
Human T-lymphotropic virus 1
1
2008
28
0.020
 Why?
Longitudinal Studies
1
2015
2720
0.020
 Why?
Rabbits
2
1999
779
0.020
 Why?
T-Lymphocytes
1
2016
1936
0.020
 Why?
National Institutes of Health (U.S.)
1
2008
122
0.020
 Why?
In Vitro Techniques
2
1999
1087
0.020
 Why?
Phenotype
1
2015
3075
0.020
 Why?
Apoptosis
1
2015
2492
0.020
 Why?
Biomarkers
1
2017
3968
0.020
 Why?
Fibroblasts
2
2000
953
0.010
 Why?
Transcription Factors
1
2011
1647
0.010
 Why?
Infant, Newborn
1
2013
5756
0.010
 Why?
Peptide Chain Termination, Translational
1
2000
5
0.010
 Why?
Fetal Proteins
1
2000
16
0.010
 Why?
Genes, Dominant
1
2000
93
0.010
 Why?
Chromosomes, Human
1
2000
41
0.010
 Why?
Fibrosarcoma
1
2000
21
0.010
 Why?
DNA, Complementary
1
2000
270
0.010
 Why?
Protein Subunits
1
2000
233
0.010
 Why?
Quinones
1
1999
9
0.010
 Why?
RNA-Directed DNA Polymerase
1
1999
34
0.010
 Why?
Lactams, Macrocyclic
1
1999
49
0.010
 Why?
Benzoquinones
1
1999
48
0.010
 Why?
Transfection
1
2000
915
0.010
 Why?
Carcinoma, Renal Cell
1
2000
179
0.010
 Why?
Cyclosporine
1
1999
263
0.010
 Why?
Molecular Chaperones
1
1999
182
0.010
 Why?
Half-Life
1
1997
162
0.010
 Why?
Neoplasm Proteins
1
2000
419
0.010
 Why?
RNA, Long Noncoding
1
1999
179
0.010
 Why?
Adenosine Triphosphate
1
1999
479
0.010
 Why?
Recombinant Proteins
1
1999
1308
0.010
 Why?
Skin
1
2000
727
0.010
 Why?
Flow Cytometry
1
1997
1159
0.010
 Why?
Prostatic Neoplasms
1
2000
998
0.010
 Why?
Aisner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (414) concept(s)
_
Co-Authors Expand Description
See all (84) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)